Your browser doesn't support javascript.
loading
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez, Gema; Rojas-Rivera, Jorge; Logt, Anne-Els van de; Justino, Joana; Sevillano, Angel; Caravaca-Fontán, Fernando; Ávila, Ana; Rabasco, Cristina; Cabello, Virginia; Varela, Alfonso; Díez, Montserrat; Martín-Reyes, Guillermo; Diezhandino, Marian Goicoechea; Quintana, Luis F; Agraz, Irene; Gómez-Martino, Juan Ramón; Cao, Mercedes; Rodríguez-Moreno, Antolina; Rivas, Begoña; Galeano, Cristina; Bonet, Jose; Romera, Ana; Shabaka, Amir; Plaisier, Emmanuelle; Espinosa, Mario; Egido, Jesus; Segarra, Alfonso; Lambeau, Gérard; Ronco, Pierre; Wetzels, Jack; Praga, Manuel.
Affiliation
  • Fernández-Juárez G; Nephrology Division, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Rojas-Rivera J; Nephrology Division, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
  • Logt AV; Nephrology Division, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Justino J; Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Université Côte d'Azur, Centre National de la Recherche Scientifique (CNRS), Valbonne Sophia Antipolis, France.
  • Sevillano A; Nephrology Division, Instituto de Investigación Hospital Universitario 12 Octubre, Madrid, Spain.
  • Caravaca-Fontán F; Nephrology Division, Instituto de Investigación Hospital Universitario 12 Octubre, Madrid, Spain.
  • Ávila A; Nephrology Division, Hospital Dr Peset, Valencia, Spain.
  • Rabasco C; Nephrology Division, Hospital Reina Sofía, Córdoba, Spain.
  • Cabello V; Nephrology Division, Hospital Virgen del Rocío, Sevilla, Spain.
  • Varela A; Nephrology Division, Hospital Virgen de la Victoria de Málaga, Málaga, Spain.
  • Díez M; Fundació Puigvert, Nephrology Division, Institut Investigaci Biosanitaria Sant Pau, Autonomous University of Barcelona (UAB), Barcelona, Spain.
  • Martín-Reyes G; Nephrology Division, Hospital Regional Universitario de Málaga, Málaga, Spain.
  • Diezhandino MG; Nephrology Division, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Quintana LF; Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud (CSUR), Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Agraz I; Nephrology Division, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Gómez-Martino JR; Nephrology Division, Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Cao M; Nephrology Division, Hospital Universitario de A Coruña, A Coruña, Spain.
  • Rodríguez-Moreno A; Nephrology Division, Hospital Clínico San Carlos, Madrid, Spain.
  • Rivas B; Nephrology Division, Hospital Universitario La Paz, Madrid, Spain.
  • Galeano C; Nephrology Division, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Bonet J; Nephrology Division, Hospital Germans Trias i Pujol, Barcelona, Spain.
  • Romera A; Nephrology Division, Hospital de Ciudad Real, Ciudad Real, Spain.
  • Shabaka A; Nephrology Division, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Plaisier E; Sorbonne Université, Université Pierre et Marie Curie Paris 06, and Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S1155, Paris, France; Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique - Hôpital de Jour Néphrologie - Hôpital TENON-Assistance
  • Espinosa M; Nephrology Division, Hospital Reina Sofía, Córdoba, Spain.
  • Egido J; Nephrology Division, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
  • Segarra A; Nephrology Division, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Lambeau G; Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Université Côte d'Azur, Centre National de la Recherche Scientifique (CNRS), Valbonne Sophia Antipolis, France.
  • Ronco P; Sorbonne Université, Université Pierre et Marie Curie Paris 06, and Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S1155, Paris, France; Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique - Hôpital de Jour Néphrologie - Hôpital TENON-Assistance
  • Wetzels J; Nephrology Division, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Praga M; Nephrology Division, Instituto de Investigación Hospital Universitario 12 Octubre, Madrid, Spain; Department of Medicine, Complutense University, Madrid, Spain. Electronic address: mpragat@senefro.org.
Kidney Int ; 99(4): 986-998, 2021 04.
Article in En | MEDLINE | ID: mdl-33166580
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, Membranous / Tacrolimus Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Kidney Int Year: 2021 Document type: Article Affiliation country: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glomerulonephritis, Membranous / Tacrolimus Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Kidney Int Year: 2021 Document type: Article Affiliation country: España